Search research articles
Contact Us
Filters
Showing results (11-20 of 64) with videos related to
Page
of 7
Sort By:
Annals of Surgical Oncology
|
June 21, 2024
The Association of Mismatch Repair Status with Microscopically Positive (R1) Margins in Stage III Colorectal Cancer: A Retrospective Cohort Study
Henry G Smith, Nis H Schlesinger, Deepthi Chiranth, et al.
Annals of Surgery
|
July 15, 2024
Introducing Neoadjuvant Immunotherapy for Colorectal Cancer: Advancing the Frontier
Adile Orhan, Tobias F Justesen, Hans Raskov, et al.
Ugeskrift for Laeger
|
January 29, 2026
[Multidisciplinary team conferences]
Henriette List, Lars Lund, Torben Riis Rasmussen, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 19, 2023
Impact of adjuvant chemotherapy on long-term overall survival in patients with high-risk stage II colon cancer: a nationwide cohort study
Victoria Rosberg, Mikkel Jessen, Camilla Qvortrup, et al.
BMJ Open
|
June 22, 2023
Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol
Tobias Freyberg Justesen, Ismail Gögenur, Line Schmidt Tarpgaard, et al.
Ugeskrift for Laeger
|
February 11, 2021
[Phenotype- or genotype test for dihydropyrimidin dehydrogenase deficiency before treatment with a fluoropyrimidine]
Stig Ejdrup Andersen, Niels Herluf Paulsen, Per Pfeiffer, et al.
Annals of Surgical Oncology
|
August 6, 2022
ctDNA for Risk of Recurrence Assessment in Patients Treated with Neoadjuvant Treatment: A Systematic Review and Meta-analysis
Mikail Gögenur, Noor Al-Huda Hadi, Camilla Qvortrup, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 20, 2015
Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?
Laurids Ø Poulsen, Camilla Qvortrup, Per Pfeiffer, et al.
Ugeskrift for Laeger
|
December 18, 2023
Adile Orhan, Sara Mørup, Laurids Østergaard Poulsen, et al.
BMC Cancer
|
August 18, 2017
Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
Stine Braendegaard Winther, Pia Österlund, Åke Berglund, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 64) with videos related to
Sort By:
Page
of 7
Annals of Surgical Oncology
|
June 21, 2024
The Association of Mismatch Repair Status with Microscopically Positive (R1) Margins in Stage III Colorectal Cancer: A Retrospective Cohort Study
Henry G Smith, Nis H Schlesinger, Deepthi Chiranth, et al.
Annals of Surgery
|
July 15, 2024
Introducing Neoadjuvant Immunotherapy for Colorectal Cancer: Advancing the Frontier
Adile Orhan, Tobias F Justesen, Hans Raskov, et al.
Ugeskrift for Laeger
|
January 29, 2026
[Multidisciplinary team conferences]
Henriette List, Lars Lund, Torben Riis Rasmussen, et al.
Acta Oncologica (Stockholm, Sweden)
|
September 19, 2023
Impact of adjuvant chemotherapy on long-term overall survival in patients with high-risk stage II colon cancer: a nationwide cohort study
Victoria Rosberg, Mikkel Jessen, Camilla Qvortrup, et al.
BMJ Open
|
June 22, 2023
Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol
Tobias Freyberg Justesen, Ismail Gögenur, Line Schmidt Tarpgaard, et al.
Ugeskrift for Laeger
|
February 11, 2021
[Phenotype- or genotype test for dihydropyrimidin dehydrogenase deficiency before treatment with a fluoropyrimidine]
Stig Ejdrup Andersen, Niels Herluf Paulsen, Per Pfeiffer, et al.
Annals of Surgical Oncology
|
August 6, 2022
ctDNA for Risk of Recurrence Assessment in Patients Treated with Neoadjuvant Treatment: A Systematic Review and Meta-analysis
Mikail Gögenur, Noor Al-Huda Hadi, Camilla Qvortrup, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 20, 2015
Review on adjuvant chemotherapy for rectal cancer - why do treatment guidelines differ so much?
Laurids Ø Poulsen, Camilla Qvortrup, Per Pfeiffer, et al.
Ugeskrift for Laeger
|
December 18, 2023
Adile Orhan, Sara Mørup, Laurids Østergaard Poulsen, et al.
BMC Cancer
|
August 18, 2017
Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
Stine Braendegaard Winther, Pia Österlund, Åke Berglund, et al.
Page
of 7